Relmada TherapeuticsRLMD 
$3.491.45%24h
1.45%24h
Global rank20979
Market cap$105.05M
Change 7d-
YTD Performance-17.69%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Relmada Therapeutics (RLMD)
As of October 2024, Relmada Therapeutics has a market cap of $105.05M. This makes Relmada Therapeutics the world's 20979th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Relmada Therapeutics from 2014 to 2024
-
Value:-
Market cap history of Relmada Therapeutics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $156.52M | 25.60% |
| 2023 | $124.61M | 18.62% |
| 2022 | $105.05M | -84.51% |
| 2021 | $678.13M | -29.75% |
| 2020 | $965.28M | -17.77% |
| 2019 | $1.17B | 747.83% |
| 2018 | $138.46M | 53.33% |
| 2017 | $90.30M | -31.19% |
| 2016 | $131.23M | -56.40% |
| 2015 | $300.99M | -83.87% |
| 2014 | $1.87B | - |
RLMD Market Cap Today is $105.05M 1.45% - 31 Oct 2024
View largest stocks by market cap 
